Skip to main content

Table 1 Clinical and laboratory findings of cases 1–3

From: Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype

 

Case 1

Case 2

Case 3

Gender

Female

Female

Female

Age at presentation

Neonate

22 months

16 years

Failure to thrive

Yes

Unknown

Unknown

Rash

No

Yes

Unknown

ILD

Yes

Yes

Yes

Arthritis

No

Polyarticular JIA

Polyarticular JIA

CRP (mg/L)

56

< 5–46

3a

Hb (g/L)

7.1 (NR 11.4–14.1)

11.1 (NR 11.5–16.5)

12.1 (NR 11.5–16.5)

C3 (g/L)

1.47 (NR 0.9–1.8)

1.65 (NR 0.75–1.65)

Unknown

C4 (g/L)

0.24 (NR 0.1–0.4)

0.2 (NR 0.14–0.54)

Unknown

IgG (g/L)

11.49 (NR 2.4–8.8)

26.0 (NR 6.0–16.0)

10.10 (NR 6.0–16.0)

IgA (g/L)

0.66 (NR 0.1–0.5)

3.5 (NR 0.5–2.4)

3.06 (NR 0.8–2.8)

IgM (g/L)

1.36 (NR 0.2–1.0)

2.1 (NR 0.5–1.8)

1.26 (NR 0.5–1.9)

Anti-smooth muscle

Positive

Negative

Negative

ANA

Negative

1:320

1:80/negativeb

ENA

Negative

Negative

Negative

Anti-dsDNA (mg/L)

Negative

Negative

1.2

RF (IU/mL)

Negative

123

797

Anti-CCP

Not performed

Negative

Not performed

  1. ANA Anti-nuclear antibody (NR < 1:80), Anti-CCP Anti-cyclic citrullinated peptide, Anti-dsDNA (NR < 5 mg/L), Anti-smooth muscle (NR < 1:10), C Complement (< 5 mg/l), CRP C-reactive protein, ENA Extractable nuclear antigen (NR < 1:80), Hb Haemoglobin, Ig Immunoglobulin, ILD Interstitial lung disease, NR Normal range, RF Rheumatoid factor (NR < 30 IU/mL). aOn single measurement. bFirst test was positive with value shown, second test was negative